Seto Pharmaceuticals (Opc) Private Limited - Company Profile

It is a business services enterprise based in Noida, Uttar Pradesh, India, established in 2019.
2019 Noida, Uttar Pradesh, India Struck Off
Last Updated:
About Seto Pharmaceuticals (Opc) Private Limited

Seto Pharmaceuticals (Opc) Private Limited, Engaging in other services within the business services sector, it holds CIN: U74999UP2019OPC115136. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Formerly known as Tagen Pharmaceuticals (Opc) Private Limited. Its leadership includes Vineet Anand (Nominee), Nitesh Singh Chauhan (Director). Past directors included Vineet Anand. Its latest balance sheet filed on 31 March 2022. It is based at F 1302, Great Value Sharanam, Sector 107, Noida, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999UP2019OPC115136

  • Registration Number

    115136

  • Incorporation Date

    27 March 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 6 Year, 11 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** %
  • Profit Growth **** -10460.86%
  • Ebitda **** -31570.23%
  • Total Assets **** %
Company report

Seto Pharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Seto Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Seto Pharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Vineet Anand Nominee 27 Mar 2019 Current
Nitesh Singh Chauhan Director 27 Mar 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Seto Pharmaceuticals (Opc).

Seto Pharmaceuticals (Opc) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10460.86% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Seto Pharmaceuticals (Opc) revenue growth over time
Seto Pharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
-10460.86%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
-31570.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Seto Pharmaceuticals (Opc)?

Unlock access to Seto Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Seto Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Seto Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Seto Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seto Pharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Seto Pharmaceuticals (Opc)
Recent Activity within the Organization
  • Balance Sheet

    The activity Seto Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kanpur. was completed.

  • Director Appointment

    The activity Vineet Anand was appointed as a Nominee was appointed as a Nominee on 27 Mar 2019 & has been associated with this company since 6 years 11 months . was completed.

  • Director Appointment

    The activity Nitesh Singh Chauhan was appointed as a Director was appointed as a Director on 27 Mar 2019 & has been associated with this company since 6 years 11 months . was completed.

  • Company Incorporation

    Seto Pharmaceuticals (Opc) Private Limited was registered on 27 Mar 2019 with Roc Kanpur & aged 6 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Seto Pharmaceuticals (Opc) Private Limited?

The CIN of Seto Pharmaceuticals (Opc) Private Limited is U74999UP2019OPC115136.

Where is Seto Pharmaceuticals (Opc) Private Limited headquartered?

Seto Pharmaceuticals (Opc) Private Limited is headquartered at F 1302, Great Value Sharanam, Sector 107, Noida, Noida, Uttar Pradesh, 201301.

When was Seto Pharmaceuticals (Opc) Private Limited incorporated?

Seto Pharmaceuticals (Opc) Private Limited was incorporated on 27 March 2019.

Who are the current directors of Seto Pharmaceuticals (Opc) Private Limited?

The current directors of Seto Pharmaceuticals (Opc) Private Limited are

What is the primary industry of Seto Pharmaceuticals (Opc) Private Limited?

The primary industry of Seto Pharmaceuticals (Opc) Private Limited is Business Services.

Is Seto Pharmaceuticals (Opc) Private Limited a listed company?

Seto Pharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Seto Pharmaceuticals (Opc) Private Limited?

The authorized capital of Seto Pharmaceuticals (Opc) Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available